Back to the feed

EU tracker

2023/0131(COD)

Authorisation and supervision of medicinal products for human use and governing rules for the European Medicines Agency

SANT · Tiemo Wölken (S&D)

10 November 2026  |  Lead committee adopted its 2nd-reading recommendation

What's next: Plenary decides on the Council's position within the 3-month (+1 on request) second-reading window: approve it or stay silent (the act is adopted), amend it, or reject it — amendment or rejection needs an absolute majority of all MEPs (361 of 720).

Posted 10 November 2026

Sign in to vote or follow